Reply to B. Freidlin et al-Reference-Cited by-同舟云学术

Reply to B. Freidlin et al

Published:2024-04-20 Issue:12 Volume:42 Page:1455-1456
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lee Choong-kun¹^ORCID,Park Sejung¹^ORCID,Nam Chung Mo¹^ORCID,Chung Hyun Cheol¹^ORCID,Rha Sun Young¹^ORCID

Affiliation:

1. Choong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei...

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.24.00012

Reference10 articles.

1. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study

2. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

3. Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxiebasierte Deeskalation der Radiochemotherapie;InFo Hämatologie + Onkologie;2024-07